Contemporary reviews describe GLP 1 medications as incretin based therapies that produce clinically meaningful HbA1c reductions in trials along with substantial, dose dependent weight loss when prescribed at obesity indicated doses
Temporary Flushing or Warmth You may experience a warm or flushed feeling after injection due to increased blood flow or vasodilation which occurs when peptides are absorbed
Wochenschr 133, 484491
5 And in particular, they found that it helped boost the hormonal response to exercise
The study followed a target trial emulation design that used data from electronic health records (EHR) from 2014 to 2024 and investigated incidence of 14 cancer types, including 13 obesity-associated cancers (liver, thyroid, pancreatic, bladder, colorectal, kidney, breast, endometrial, meningioma, upper gastrointestinal, ovarian, multiple myeloma, prostate) and lung cancer
As of 2014 ~29.1 million Americans, or 9.3% of the population (niddk.nih.gov - Feb 2017)